Tvax Biomedical LLC

TVAX Biomedical LLC, located in Overland Park, KS, is pioneering a novel approach to cancer treatment through its innovative TVAX Immunotherapy platform. This personalized T cell therapy aims to enhance clinical outcomes for patients across all cancer types with lower toxicity and the potential for significant changes in cancer treatment methodologies.

The company's lead product candidate, TVI-Brain-1, is currently under evaluation for the treatment of glioblastoma, a form of brain cancer, with the United States Food and Drug Administration granting it Fast Track Designation for its pivotal phase 2b clinical trial. TVAX Biomedical's approach epitomizes hope and progress in revolutionizing cancer care, focusing on patient-centric solutions.

Generated from the website